Surface Modified Carvacrol-rich Satureja khuzestanica Essential Oil Nanoemulsion: A Novel Paclitaxel Formulation Induced Apoptosis on Paclitaxel-Resistant Breast Cancer Cells

Background: The ability of cancer cells to develop multidrug resistance (MDR) is a major challenge in modern chemotherapy. The current generation of commercially available paclitaxel formulations have not been designed to treat resistant tumours. In this study, a nanoemulsion-based delivery system w...

Full description

Bibliographic Details
Published in:	Pharmaceutical Sciences
Main Authors:	Zeinab Mazarei, Houri Sepehri, Ladan Delphi, David Julian McClements, Hasan Rafati
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences 2024-01-01
Subjects:	breast cancer multidrug resistance nanoemulsion paclitaxel tpgs
Online Access:	https://ps.tbzmed.ac.ir/PDF/ps-30-85.pdf

Similar Items

Development and optimization of TPGS/P84 mixed polymeric micelles: enhanced stability and anticancer effect of paclitaxel against tumor therapy
by: Qi Huang, et al.
Published: (2023-05-01)

Novel nanoemulsion-loaded hydroxyl propyl methyl cellulose films as bioactive food packaging materials containing Satureja khuzestanica essential oil
by: Fatemeh Aghajani, et al.
Published: (2024-12-01)

Retraction: Development and optimization of TPGS/P84 mixed polymeric micelles: enhanced stability and anticancer effect of paclitaxel against tumor therapy
by: Qi Huang, et al.
Published: (2024-02-01)

Facile fabrication of TPGS-PCL polymeric nanoparticles for paclitaxel delivery to breast cancer: investigation of antiproliferation and apoptosis induction
by: Tong Chen, et al.
Published: (2024-12-01)

Frankincense oil-loaded nanoemulsion formulation of paclitaxel and erucin: A synergistic combination for ameliorating drug resistance in breast cancer: In vitro and in vivo study
by: Harneetpal Kaur, et al.
Published: (2022-10-01)

Phosphatidylcholine-Based Nanoemulsions for Paclitaxel and a P-Glycoprotein Inhibitor Delivery and Breast Cancer Intraductal Treatment
by: Giovanna Cassone Salata, et al.
Published: (2022-09-01)

In Vitro Efficacy Studies for Evaluating the Activity of a Self-Assembled Nanoemulsion Formulation of Paclitaxel on Breast and Ovarian Cancer Cells
by: Mukta Bagul, et al.
Published: (2014-09-01)

Optimizing Paclitaxel Oral Absorption and Bioavailability: TPGS Co-Coating via Supercritical Anti-Solvent Fluidized Bed Technology
by: Zicheng Zhong, et al.
Published: (2024-03-01)

Utilizing TPGS for Optimizing Quercetin Nanoemulsion for Colon Cancer Cells Inhibition
by: Hadel A. Abo Enin, et al.
Published: (2022-09-01)

In vitro Evaluation of Antiproliferative Effects of Self-assembling Nanoemulsion of Paclitaxel on Various Cancer Cell Lines
by: Mukta Bagul, et al.
Published: (2010-06-01)

Carvacrol Protects Against Paclitaxel-Induced Retinal and Optic Nerve Cytotoxicity: A Histopathological Study
by: Emine Çinici, et al.
Published: (2020-12-01)

Protective Effect of Carvacrol against Paclitaxel-Induced Ototoxicity in Rat Model
by: Fatma Atalay, et al.
Published: (2020-12-01)

Improved oral absorption and anti-lung cancer activity of paclitaxel-loaded mixed micelles
by: Jian Hou, et al.
Published: (2017-01-01)

Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein
by: Wenwen Xu, et al.
Published: (2023-11-01)

Nanomicellar Prodrug Delivery of Glucose-Paclitaxel: A Strategy to Mitigate Paclitaxel Toxicity
by: Yan D, et al.
Published: (2025-02-01)

Development, Characterization, and Immunomodulatory Evaluation of Carvacrol-loaded Nanoemulsion
by: Amanda Gabrielle Barros Dantas, et al.
Published: (2021-06-01)

Lipiodol nanoemulsions stabilized with polyglycerol-polycaprolactone block copolymers for theranostic applications
by: Trang Huyen Le Kim, et al.
Published: (2017-10-01)

Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
by: Yafan Yang, et al.
Published: (2023-03-01)

Safety of nab-paclitaxel following an allergic reaction to paclitaxel: A single institution retrospective study
by: Swapna Kochuveettil, et al.
Published: (2024-10-01)

Pharmacokinetic evaluation of paclitaxel, albumin-binding paclitaxel, and liposomal-encapsulated albumin-binding paclitaxel upon gastric subserosal administration
by: Yoontaek Lee, et al.
Published: (2024-06-01)

Micellar paclitaxel in the treatment of patients with tumors of the female reproductive system
by: A. G. Kedrova, et al.
Published: (2019-11-01)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
by: Ines Klein, et al.
Published: (2021-09-01)

Distinct safety profiles of albumin-bound nab-paclitaxel and paclitaxel in pancreatic cancer focusing on hematologic and hepatobiliary risks
by: Nan Qin, et al.
Published: (2025-08-01)

Incidence of neuropathy with weekly paclitaxel and role of oral glutamine supplementation for prevention of paclitaxel induced peripheral neuropathy randomized controlled trial
by: Waseem Abbas, et al.
Published: (2018-01-01)

Improved antitumor efficacy of paclitaxel with nano-formulation in breast cancer
by: Ding Shuang, et al.
Published: (2017-06-01)

In vitro antitrichomonal activity of Satureja khuzestanica and main essential oil components carvacrol, thymol, and eugenol
by: Faezeh Karami, et al.
Published: (2023-01-01)

Efficacy of albumin-bound paclitaxel versus paclitaxel in esophageal cancer: a systematic review and meta-analysis
by: Jiayang Song, et al.
Published: (2025-08-01)

Management of paclitaxel-induced neurotoxicity
by: Manisha Bhutani, et al.
Published: (2011-12-01)

Anticancer Activity of Paclitaxel-Loaded Mesoporous Silica Nanoparticles in B16F10 Melanoma-Bearing Mice
by: Jihoon Lee, et al.
Published: (2025-08-01)

Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy
by: Milda Girdenytė, et al.
Published: (2024-11-01)

PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers
by: Jinling Yu, et al.
Published: (2020-03-01)

PENURUNAN NILAI HANTARAN TULANG PADA PENDERITA KARSINOMA NASOFARING DENGAN KEMOTERAPI BERBASIS PLATINUM: KOMBINASI NEOADJUVANT PACLITAXEL-CISPLATIN DAN PACLITAXEL-CARBOPLATIN
by: Cika Apriliana, et al.
Published: (2019-02-01)

Synthesis, Biological Evaluation and Low-Toxic Formulation Development of Glycosylated Paclitaxel Prodrugs
by: Yukang Mao, et al.
Published: (2018-12-01)

Peptide Aptamer–Paclitaxel Conjugates for Tumor Targeted Therapy
by: Xinyang Shen, et al.
Published: (2024-12-01)

Should paclitaxel be considered an old generation DCB? The limus era
by: Gaetano di Palma, et al.
Published: (2021-12-01)

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
by: Demuytere J, et al.
Published: (2024-01-01)

The effect of propofol on chemosensitivity of paclitaxel in cervical cancer cells
by: Yanshan Jin, et al.
Published: (2023-07-01)

Response to Paclitaxel in an Adult Patient with Advanced Kaposiform Hemangioendothelioma
by: José Maurício Mota, et al.
Published: (2016-08-01)

Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival
by: Marieke Schmidt, et al.
Published: (2024-12-01)

Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future
by: Abhishesh Kumar Mehata, et al.
Published: (2023-02-01)